-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Author Archive: Jim Greenwood
Biotech Depends on Policies that Promote Innovation
The biotechnology industry’s endeavor to transform science into therapy for a previously untreatable disease is the subject of a new movie, “Extraordinary Measures.” The movie is the story of John Crowley, founder of Novazyme, and his struggle to find funding to develop a therapy for Pompe disease. The story, though, may not seem so out of the ordinary to those in the biotechnology industry who conduct vital research and development on products that will help Read More >
Welcome to BIOtech Now
BIOtech Now is the first in a number of new products from BIO intended to enhance our communications with the biotech community — not only with our members, but with other stakeholders as well. This monthly e-newsletter, combined with its web site, serves as our flagship in that effort. BIOtech Now will: Offer original content that emphasizes the business needs of the industry. Highlight BIO’s advocacy efforts. Provide a portal to all BIO activities and Read More >
Food and Energy Security: Raising AgriBio’s Profile
The world’s population is projected to reach 9.1 billion by the middle of this century. Feeding that number of people — in addition to producing animal feed, fiber and biofuels — will require a 70 percent increase in overall agricultural production, primarily in the developing world, according to the United Nations Food and Agriculture Organization (UN FAO). That is why the priorities for BIO’s Food and Agriculture Section in the coming year start with increasing Read More >
Efforts to Restrict Gene Patenting and Licensing Would Threaten Advances in Public Health and Harm the National Economy
On February 4th, BIO hosted a media briefing on how efforts to restrict gene patenting and licensing would threaten advances in public health and harm the national economy. Participants included: BIO President & CEO Jim Greenwood; Senator Birch Bayh, co-author of the Bayh-Dole Act; Brian Stanton, Ph.D., Task Force Member on Intellectual Property and Access to Genetic Testing; Jim Davis, Ph.D., J.D., General Counsel of Human Genome Sciences, Inc.; Jon Soderstrom, Ph.D., Managing Director of Read More >
Global Dialogue on Meeting Food Needs for the Next Generation
When we look at the challenges affecting our world today, many come to mind – energy demand, food security and climate change, just to name a few. Biotechnology provides tools to meet all of these challenges. The sustainable farming practices afforded to today’s modern farmers allow us to produce more food, fuel and fiber on less land with less environmental impact. These technologies – and the policies and infrastructures needed to realize their benefit – Read More >




